| Catalog_no | ADMC0955 |
| Product_name | Vilanterol trifenatate |
| Category | 抑制剂与激动剂 |
| Size | 10mg/50mg/100mg |
| Price | 4000.00/9500.00/14780.00 |
| Specificity | Target: Adrenergic Receptor . Fields: Vilanterol trifenatate (GW642444)is a novel, inhaled, long-acting β(2) agonist with inherent 24-h activity under development as a once-daily combination therapy with an inhaled corticosteroid for COPD and asthma. |
| Dilution | pEC50: 10.37±0.05 (β2-adrenoceptor), 6.98±0.03 (β1-adrenoceptor), 7.36±0.03 (β3-adrenoceptor)[1] |
| Purification | >98% |
| Concentration | 靶点：Adrenergic Receptor;IC50：pEC50: 10.37±0.05 (β2-adrenoceptor), 6.98±0.03 (β1-adrenoceptor), 7.36±0.03 (β3-adrenoceptor)[1] |
| Storage_stability | 2 years -20°C Powder, 2 weeks4°C in DMSO,6 months-80°C in DMSO |
| othername | GW642444M; GW 642444M; GW-642444M |
| Observed_band | 774.77 |
| Notes | Vilanterol trifenatate (GW642444)is a novel, inhaled, long-acting β(2) agonist with inherent 24-h activity under development as a once-daily combination therapy with an inhaled corticosteroid for COPD and asthma. pEC50: 10.37±0.05 (β2-adrenoceptor), |
| Instructions | 
查看与下载 |
| Share |
|
